Reply: To PMID 24798001

Farhan Haq¹, Sung-Min Ahn^{1

2

3}

Affiliations

¹ Center for Cancer Genome Discovery Asan Institute for Life Science, University of Ulsan College of Medicine Asan Medical Center Seoul, Korea.
² Department of Oncology, University of Ulsan College of Medicine Asan Medical Center Seoul, Korea.
³ Department of Bioinformatics, University of Ulsan College of Medicine Asan Medical Center Seoul, Korea.

Comment

Farhan Haq et al. Hepatology. 2015 Oct.

. 2015 Oct;62(4):1324-5.

doi: 10.1002/hep.27740. Epub 2015 Apr 8.

Farhan Haq¹, Sung-Min Ahn^{1

2

3}

¹ Center for Cancer Genome Discovery Asan Institute for Life Science, University of Ulsan College of Medicine Asan Medical Center Seoul, Korea.
² Department of Oncology, University of Ulsan College of Medicine Asan Medical Center Seoul, Korea.
³ Department of Bioinformatics, University of Ulsan College of Medicine Asan Medical Center Seoul, Korea.

No abstract available

Comment on

Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification.
Ahn SM, Jang SJ, Shim JH, Kim D, Hong SM, Sung CO, Baek D, Haq F, Ansari AA, Lee SY, Chun SM, Choi S, Choi HJ, Kim J, Kim S, Hwang S, Lee YJ, Lee JE, Jung WR, Jang HY, Yang E, Sung WK, Lee NP, Mao M, Lee C, Zucman-Rossi J, Yu E, Lee HC, Kong G. Ahn SM, et al. Hepatology. 2014 Dec;60(6):1972-82. doi: 10.1002/hep.27198. Epub 2014 Sep 22. Hepatology. 2014. PMID: 24798001
Targeting FGF19 binding to its receptor system: a novel therapeutic approach for hepatocellular carcinoma.
Panera N, Ceccarelli S, Nobili V, Alisi A. Panera N, et al. Hepatology. 2015 Oct;62(4):1324. doi: 10.1002/hep.27741. Epub 2015 Mar 20. Hepatology. 2015. PMID: 25677789 No abstract available.